Phase II Trial of Carboplatin and Everolimus (RAD001) in Metastatic Castrate Resistant Prostate Cancer (CRPC) Pretreated With Docetaxel Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Carboplatin (Primary) ; Everolimus (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 12 Sep 2015 Primary endpoint (Time to disease progression) has not been met according to the results published in the Urology.
- 12 Sep 2015 Results published in the Urology.